Economic Evaluation of Sedative Deprescribing in Older Adults by Community Pharmacists
- 16 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 76 (6) , 1061-1067
Abstract
Background: Sedative use in older adults increases the risk of falls, fractures, and hospitalizations. The D-PRESCRIBE (Developing Pharmacist-Led Research to Educate and Sensitize Community Residents to the Inappropriate Prescriptions Burden in the Elderly), pragmatic randomized clinical trial demonstrated that community-based, pharmacist-led education delivered simultaneously to older adults and their primary care providers reduce the use of sedatives by 43% over 6 months. However, the associated health benefits and cost savings have yet to be described. This study evaluates the cost-effectiveness of the D-PRESCRIBE intervention compared to usual care for reducing the use of potentially inappropriate sedatives among older adults.Methods: A cost-utility analysis from the public health care perspective of Canada estimated the costs and quality-adjusted life-years (QALYs) associated with the D-PRESCRIBE intervention compared to usual care over a 1-year time horizon. Transition probabilities, intervention effectiveness, utility, and costs were derived from the literature. Probabilistic analyses were performed using a decision tree and Markov model to estimate the incremental cost-effectiveness ratio.Results: Compared to usual care, pharmacist-led deprescribing is less costly (−$1392.05 CAD) and more effective (0.0769 QALYs). Using common willingness-to-pay (WTP) thresholds of $50 000 and $100 000, D-PRESCRIBE was the optimal strategy. Scenario analysis indicated the cost-effectiveness of D-PRESCRIBE is sensitive to the rate of deprescribing.Conclusions: Community pharmacist-led deprescribing of sedatives is cost-effective, leading to greater quality-of-life and harm reduction among older adults. As the pharmacist’s scope of practice expands, consideration should be given to interprofessional models of remuneration for quality prescribing and deprescribing services.Keywords
This publication has 31 references indexed in Scilit:
- Correlates of Potentially Inappropriate Prescriptions of Benzodiazepines among Older Adults: Results from the ESA StudyCanadian Journal on Aging / La Revue canadienne du vieillissement, 2012
- The cost‐effectiveness of falls prevention interventions for older community‐dwelling AustraliansAustralian and New Zealand Journal of Public Health, 2012
- Uncovering the source of new benzodiazepine prescriptions in community‐dwelling older adults’International Journal of Geriatric Psychiatry, 2012
- Chronic insomnia, quality-of-life, and utility scores: Comparison with good sleepers in a cross-sectional international surveySleep Medicine, 2012
- Assessing the cumulative effects of exposure to selected benzodiazepines on the risk of fall-related injuries in the elderlyInternational Psychogeriatrics, 2011
- Risk of Fractures Requiring Hospitalization After an Initial Prescription for Zolpidem, Alprazolam, Lorazepam, or Diazepam in Older AdultsJournal of the American Geriatrics Society, 2011
- The cost of fall related presentations to the ED: A prospective, in-person, patient-tracking analysis of health resource utilizationOsteoporosis International, 2011
- Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adultsPharmacoepidemiology and Drug Safety, 2010
- Costs and quality of life associated with osteoporosis-related fractures in SwedenOsteoporosis International, 2005
- The Costs of Benzodiazepine-Associated Hospital-Treated Fall Injuries in the EU: A Pharmo StudyDrugs & Aging, 2003